US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

154.47

-0.0400-0.03%

Post-market: 154.43-0.0400-0.03%16:04 EDT

Volume:8.67M

Turnover:1.34B

Market Cap:10.16B

PE:8.47

High:156.74

Open:156.41

Low:153.58

Close:154.51

52wk High:169.89

52wk Low:101.01

Shares:65.80M

Float Shares:65.80M

Volume Ratio:1.03

T/O Rate:13.18%

Dividend:0.55

Dividend Rate:0.35%

EPS(TTM):18.23

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Ourea Biotech HK Limited Sells 6 Million Shares of GenFleet-B (02595) at HK$27.3 Each

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Ocular Therapeutix (OCUL) and Regeneron (REGN)

SI-Bone (SIBN) Gets a Buy from Canaccord Genuity

Analysts Have Conflicting Sentiments on These Healthcare Companies: Roche Holding AG (OtherRHHVF), Adagene (ADAG) and Inventiva (IVA)

Analysts’ Top Healthcare Picks: AbbVie (ABBV), Quantum-Si (QSI)

Goldman Sachs Names 2 Undervalued Healthcare Stocks to Buy With At Least 50% Upside

Fortis, IHH to Cooperate With Court-Ordered Forensic Audit on 2018 Stake Deal

Man Group PLC : Form 8.3 - Spire Healthcare Group Plc

Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Envista Holdings (NVST) and Regeneron (REGN)

Humanwell Healthcare to Raise 3.35 Billion Yuan From Share Placement

MT Newswires Live

Health Care Roundup: Market Talk

Ping An Healthcare to Renew Agreements with Ping An Life Insurance

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Inventiva (IVA) and Moderna (MRNA)

Cannara Biotech: Analyst Maintains Buy Rating and $3.00 Price Target on Growth Momentum and Shareholder-Friendly Capital Actions

Buy Rating Backed by Strong Rare Liver Disease Franchise, Expanding Commercial Footprint, and Favorable Risk‑Reward at Mirum Pharmaceuticals

IHH Healthcare Says India Supreme Court Disposes of Fortis Forensic Audit Petition

MT Newswires Live

Promisia moves to fast-track full ownership of Golden View Village

CEO’s Bold Move Signals Growing Confidence in Biotech Challenger

HK Opening Bell | Market Mixed At Open; Biotech Stocks Firm; Akeso Jumps 8%

HK Opening Bell

Healthcare Stocks Rise to Start Week

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/XBI/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"Spdr S&P Biotech Etf","latestPrice":154.47,"timestamp":1790971200000,"preClose":154.51,"halted":0,"volume":8671852,"hourTrading":{"tag":"盘后","latestPrice":154.43,"preClose":154.47,"latestTime":"16:04 EDT","volume":483435,"amount":74657253.79800001,"timestamp":1790971445000,"change":-0.04,"changeRate":-0.000259,"amplitude":0.005632},"delay":0,"changeRate":-0.00025888292019928834,"floatShares":65800000,"shares":65800000,"eps":18.23,"marketStatus":"Post-Mkt","change":-0.04,"latestTime":"10-02 16:05:16 EDT","open":156.41,"high":156.74,"low":153.575,"amount":1342402082.57036,"amplitude":0.020484,"askPrice":154.6,"askSize":200,"bidPrice":154.01,"bidSize":100,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790985600000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":154.51,"sharesOutstanding":63325000,"nav":157.70852,"aum":10290480910.03,"dividendRate":0.003548,"bidAskSpread":0.000327,"preHourTrading":{"tag":"盘前","latestPrice":156.2108,"preClose":154.51,"latestTime":"09:28 EDT","volume":24787,"amount":3885699.3532,"timestamp":1790947734577,"change":1.7008,"changeRate":0.011008,"amplitude":0.015404},"postHourTrading":{"tag":"盘后","latestPrice":154.43,"preClose":154.47,"latestTime":"16:04 EDT","volume":483435,"amount":74657253.79800001,"timestamp":1790971445000,"change":-0.04,"changeRate":-0.000259,"amplitude":0.005632},"volumeRatio":1.027187,"impliedVol":0.3149,"impliedVolPercentile":0.5259},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":65800000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.027187,"shares":65800000,"dividePrice":0.5481,"high":156.74,"amplitude":0.020484,"preClose":154.51,"low":153.575,"week52Low":101.01,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":154.47,"committee":-0.333333,"eps":18.23,"divideRate":0.003548,"volume":8671852,"delay":0,"ttmEps":18.23,"open":156.41,"prevYearClose":121.93,"prevWeekClose":155.03,"prevMonthClose":157.68,"prevQuarterClose":157.68,"fiveDayClose":155.03,"twentyDayClose":164.38,"sixtyDayClose":164.28},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"},{"executeDate":"2018-03-16","recordDate":"2018-03-19","paymentDate":"2018-03-21","value":0.059081,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1198747120","title":"Ourea Biotech HK Limited Sells 6 Million Shares of GenFleet-B (02595) at HK$27.3 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1198747120","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198747120?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:28","pubTimestamp":1790681297,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on September 24, Ourea Biotech HK Limited reduced its holdings in GenFleet-B (02595) by 6 million shares at a price of HK$27.3 per...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4585","EWH","09939","XBI","BK1515","BK1574","BK4588","02595","BK4581","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216266","title":"Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Ocular Therapeutix (OCUL) and Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216266","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216266?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:10","pubTimestamp":1790680206,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Summit Therapeutics (SMMT), Ocular Therapeutix (OC...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-summit-therapeutics-smmt-ocular-therapeutix-ocul-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-summit-therapeutics-smmt-ocular-therapeutix-ocul-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","LU2362541273.HKD","LU0882574055.USD","LU0823434583.USD","LU0320765992.SGD","LU0114720955.EUR","LU2089984988.USD","OCUL","SMMT","BBH","LU2023250504.SGD","LU0029874061.USD","BK4137","XLV","IBB","BK4585","LU1974910355.USD","LU0058720904.USD","LU0823416689.USD","LU0289739699.SGD","BK4588","BK4581","HCSG","XBI","LU1917777945.USD","LU2362541513.USD","LU0128526141.USD","LU0109394709.USD","LU2362540622.SGD","LU2468319806.SGD","BK4139","BK4007","LU0823434740.USD","REGN","LU2488822045.USD","LABU","TBXU","IBBQ","LU0053666078.USD","LU2106854487.HKD","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671215009","title":"SI-Bone (SIBN) Gets a Buy from Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2671215009","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671215009?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:56","pubTimestamp":1790679373,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst Caitlin Roberts reiterated a Buy rating on SI-Bone today and set a price target of $27.00. Roberts covers the Healthcare ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/si-bone-sibn-gets-a-buy-from-canaccord-genuity-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/si-bone-sibn-gets-a-buy-from-canaccord-genuity-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BK4581","LABU","BK4588","XLV","BK4585","SIBN","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671168852","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Roche Holding AG (OtherRHHVF), Adagene (ADAG) and Inventiva (IVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671168852","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671168852?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:50","pubTimestamp":1790679012,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF), Adagene (ADAG) and Inven...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-roche-holding-ag-otherrhhvf-adagene-adag-and-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-roche-holding-ag-otherrhhvf-adagene-adag-and-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADAG","BK4007","BK4585","XBI","LU2293690249.USD","XLV","BK4588","LU2539964713.USD","RHHVF","BK4137","LU2293690082.USD","IVA","HCSG","LU0029874061.USD","LU0128526141.USD","LABU","BK4581","BK4139","LU1046234339.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671568215","title":"Analysts’ Top Healthcare Picks: AbbVie (ABBV), Quantum-Si (QSI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671568215","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671568215?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:30","pubTimestamp":1790677819,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AbbVie (ABBV), Quantum-Si (QSI) and Summit Therapeut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-abbvie-abbv-quantum-si-qsi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-abbvie-abbv-quantum-si-qsi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1989772923.USD","AGNG","LU2125909247.SGD","XBI","MEDX","FTXH","LU0868494708.USD","LU0472753341.HKD","LU0726765562.USD","LU1037948897.HKD","TRUH","VHT","ABBV","LU1670628061.USD","LU0689472784.USD","IE00B19Z3581.USD","LU0203345920.USD","LU0859254822.USD","FHLC","HCSG","LU0708994859.HKD","IE00BVYPNV92.GBP","SG9999015978.USD","RXL","LU0320765646.SGD","LU1267930490.SGD","XLV","IXJ","JDOC","GLAM","IE00BJJMRZ35.SGD","IYH","LU0234572021.USD","LU0823416689.USD","LU0942090050.USD","LU1496350502.SGD","PJP","SG9999015945.SGD","LU1720051017.SGD","IE00BGHQF631.EUR","LU0069063385.USD","LU1983299246.USD","LU2023251221.USD","PPH","LU2237443978.SGD","LU0432979614.USD","LU0029874061.USD","QSI","LABU","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671213846","title":"Goldman Sachs Names 2 Undervalued Healthcare Stocks to Buy With At Least 50% Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2671213846","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671213846?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:48","pubTimestamp":1790675280,"startTime":"0","endTime":"0","summary":"Investors have long had an interest in the healthcare sector. Some parts of it are considered recession-proof, while others bring in high returns. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/goldman-sachs-names-2-undervalued-healthcare-stocks-to-buy-with-at-least-50-upside?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/goldman-sachs-names-2-undervalued-healthcare-stocks-to-buy-with-at-least-50-upside?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGDV","LU1668664300.SGD","TCTL","LU0742534661.SGD","LU2750360997.AUD","LU0210536198.USD","GSX","NOBL","LU2471134523.USD","LU2471134796.USD","LU0048573561.USD","OCTZ","IE00BFXG1179.USD","BK4588","LU1868836914.USD","VTV","LU2265009873.SGD","LU0251142724.SGD","XBI","LU1868836591.USD","ABIG","IE0002270589.USD","LU2237443978.SGD","CGCV","LU1868836757.USD","LABU","LU2471134879.HKD","LU2237443465.HKD","HCSG","BK4550","LU0868494617.USD","ASGM","CGVV","IXJ","RULE","LU0128526141.USD","STXV","VHT","BK4137","LU2750360641.GBP","TCAF","LU2237443622.USD","LU2471134952.CNY","LU2237443895.HKD","LU0096364046.USD","BK4516","GAPR","XLV","XJUL","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671218452","title":"Fortis, IHH to Cooperate With Court-Ordered Forensic Audit on 2018 Stake Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2671218452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671218452?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:44","pubTimestamp":1790675099,"startTime":"0","endTime":"0","summary":"Fortis Healthcare Ltd. ( ($IN:FORTIS) ) has shared an update. Fortis Healthcare has disclosed that the Supreme Court of India has disposed of its S...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fortis-ihh-to-cooperate-with-court-ordered-forensic-audit-on-2018-stake-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fortis-ihh-to-cooperate-with-court-ordered-forensic-audit-on-2018-stake-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4585","BK4581","XBI","MNDmain","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671218310","title":"Man Group PLC : Form 8.3 - Spire Healthcare Group Plc","url":"https://stock-news.laohu8.com/highlight/detail?id=2671218310","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671218310?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:41","pubTimestamp":1790674860,"startTime":"0","endTime":"0","summary":"FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/29/3370567/0/en/man-group-plc-form-8-3-spire-healthcare-group-plc.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","XBI","HCSG","LABU","LU0029874061.USD","BK4137","XLV","BK4581","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671290718","title":"Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Envista Holdings (NVST) and Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671290718","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671290718?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:30","pubTimestamp":1790674217,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on 4D Molecular Therapeutics (FDMT), Envista Holdings...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-4d-molecular-therapeutics-fdmt-envista-holdings-nvst-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-4d-molecular-therapeutics-fdmt-envista-holdings-nvst-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2023250504.SGD","IBB","LU1917777945.USD","LU0889565916.HKD","LU0477156797.USD","LU0882574055.USD","LU2362541273.HKD","IE00B19Z6F94.USD","LU0114720955.EUR","LU0109394709.USD","LU0130103400.USD","LU2089984988.USD","LU2468319806.SGD","XBI","BBH","BK4139","LU0823434583.USD","LU0128526141.USD","REGN","TBXU","BK4581","BK4137","LU0823416689.USD","LU0823434740.USD","LABU","LU2237438978.USD","XLV","FDMT","LU2362540622.SGD","LU0053666078.USD","LU0130518102.USD","LU0058720904.USD","IBBQ","LU1974910355.USD","LU0029874061.USD","NVST","LU1201861165.SGD","LU0648000940.SGD","BK4588","LU0320765992.SGD","HCSG","LU0289739699.SGD","LU2362541513.USD","IE0034390439.USD","BK4585","BK4082","LU2106854487.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671297786","title":"Humanwell Healthcare to Raise 3.35 Billion Yuan From Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2671297786","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671297786?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:10","pubTimestamp":1790673013,"startTime":"0","endTime":"0","summary":"Humanwell Healthcare  plans to raise up to 3.35 billion yuan from a share placement, according to a Shanghai bourse filing on Tuesday.The company will place shares to the pharmaceutical company's controlling shareholder, China Merchants Biomedicine.The proceeds will be used for the Yichang Renfu subsidiary project, the construction of a headquarters research institute and a manufacturing base for sexual health products, the development of a digital project and the supplementation of working capital.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0096","LU0029874061.USD","BK4137","LU0128526141.USD","BK0012","600079","BK0239","BK4585","BK0028","BK4588","BK4581","HCSG","LABU","XLV","BK0185","BK0070","BK0188","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671292370","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2671292370","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671292370?lang=en_us&edition=fundamental","pubTime":"2026-09-29 16:20","pubTimestamp":1790670000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0712 GMT - Eurofins Scientific's 2027 target of an improvement i","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4103","LABU","BK4220","XBI","BK4585","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671295721","title":"Ping An Healthcare to Renew Agreements with Ping An Life Insurance","url":"https://stock-news.laohu8.com/highlight/detail?id=2671295721","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671295721?lang=en_us&edition=fundamental","pubTime":"2026-09-29 14:27","pubTimestamp":1790663256,"startTime":"0","endTime":"0","summary":"Ping An Healthcare and Technology Company  said its board has proposed to renew certain agreements with its parent-affiliated company, Ping An Life Insurance Co. of China, originally signed in 2023, according to a Monday Hong Kong bourse filing.The healthcare platform operator said it will issue a circular with final details of the agreement, including an independent board committee's recommendation and financial advisor Gram Capital's opinion on the proposed renewal, on or around Nov. 9.Ping An Healthcare's shares were last up 5% in Tuesday afternoon trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1219","BK1615","LABU","BK4588","BK1247","LU0029874061.USD","BK1515","BK4585","LU0128526141.USD","XBI","XLV","BK4137","BK1571","BK1617","01833","PAImain","BK4581","BK1142","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671829804","title":"Analysts Offer Insights on Healthcare Companies: Inventiva (IVA) and Moderna (MRNA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671829804","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671829804?lang=en_us&edition=fundamental","pubTime":"2026-09-29 13:00","pubTimestamp":1790658033,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Inventiva (IVA) and Moderna (MRNA). Inventiva (IVA...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-inventiva-iva-and-moderna-mrna-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-inventiva-iva-and-moderna-mrna-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","IDNA","MRNY","BK4551","LU0128526141.USD","WDNA","LU0029874061.USD","BK4139","BK4137","BK4534","MRNA","BK4581","MRNX","LGHT","BK4533","BK4585","HCSG","XLV","BK4588","BK4501","IVA","BK4548","BK4532","LABU","GNOM","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671172298","title":"Cannara Biotech: Analyst Maintains Buy Rating and $3.00 Price Target on Growth Momentum and Shareholder-Friendly Capital Actions","url":"https://stock-news.laohu8.com/highlight/detail?id=2671172298","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671172298?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:55","pubTimestamp":1790657728,"startTime":"0","endTime":"0","summary":"Nicholas Cortellucci, an analyst from Atrium Research, maintained the Buy rating on Cannara Biotech. The associated price target is C$3.00. Nichola...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cannara-biotech-analyst-maintains-buy-rating-and-3-00-price-target-on-growth-momentum-and-shareholder-friendly-capital-actions-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cannara-biotech-analyst-maintains-buy-rating-and-3-00-price-target-on-growth-momentum-and-shareholder-friendly-capital-actions-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671298192","title":"Buy Rating Backed by Strong Rare Liver Disease Franchise, Expanding Commercial Footprint, and Favorable Risk‑Reward at Mirum Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2671298192","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671298192?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:55","pubTimestamp":1790657719,"startTime":"0","endTime":"0","summary":"Mirum Pharmaceuticals, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Joseph Schwartz from Leerink Partne...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-backed-by-strong-rare-liver-disease-franchise-expanding-commercial-footprint-and-favorable-riskreward-at-mirum-pharmaceuticals-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-backed-by-strong-rare-liver-disease-franchise-expanding-commercial-footprint-and-favorable-riskreward-at-mirum-pharmaceuticals-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","BK4585","XBI","XLV","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671298622","title":"IHH Healthcare Says India Supreme Court Disposes of Fortis Forensic Audit Petition","url":"https://stock-news.laohu8.com/highlight/detail?id=2671298622","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671298622?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:54","pubTimestamp":1790657698,"startTime":"0","endTime":"0","summary":"IHH Healthcare  said India's Supreme Court on Sept. 25, Friday, disposed of Fortis Healthcare's  Special Leave Petition challenging a Delhi High Court order requiring a forensic audit of Fortis and certain observations concerning the company.The company's unit, Northern TK Venture, acquired a 31% stake in Fortis in 2018 through a competitive bidding process, involving a 40 billion rupees preferential allotment and a mandatory tender offer to public shareholders.IHH said the acquisition was completed months after former Fortis promoters Malvinder and Shivinder Singh had resigned from the company's board in March 2018. It said no secondary shares were acquired from them and no payments were made to them, adding that it was not a party to the dispute between Daiichi Sankyo and the former promoters.The healthcare company said it will cooperate fully with the forensic audit and remains committed to Fortis, with plans to increase its stake to 51% over the next three to five years.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LABU","XBI","XLV","BK6511","MNDmain","HCSG","BK4585","BK4581","BK6092","LU0128526141.USD","Q0F.SI","LU0029874061.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671260263","title":"Promisia moves to fast-track full ownership of Golden View Village","url":"https://stock-news.laohu8.com/highlight/detail?id=2671260263","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671260263?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:18","pubTimestamp":1790655481,"startTime":"0","endTime":"0","summary":"Promisia Healthcare Limited ( ($NZ:PHL) ) has issued an update. Promisia Healthcare has secured an option to accelerate its acquisition of the Gold...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/promisia-moves-to-fast-track-full-ownership-of-golden-view-village?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/promisia-moves-to-fast-track-full-ownership-of-golden-view-village?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","GLD","LABU","518880","GCmain","GDX","MGCmain","XLV","SGCmain","159934","BK4581","BK4585","NUGT","BK4588","SGUmain","IAU","DUST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671264727","title":"CEO’s Bold Move Signals Growing Confidence in Biotech Challenger","url":"https://stock-news.laohu8.com/highlight/detail?id=2671264727","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671264727?lang=en_us&edition=fundamental","pubTime":"2026-09-29 10:01","pubTimestamp":1790647282,"startTime":"0","endTime":"0","summary":"New insider activity at Inhibrx Biosciences Inc ( ($INBX) ) has taken place on September 28, 2026. In a notable show of confidence in Inhibrx Biosc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/ceos-bold-move-signals-growing-confidence-in-biotech-challenger-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/ceos-bold-move-signals-growing-confidence-in-biotech-challenger-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INBX","BK4588","BK4139","BK4585","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194971040","title":"HK Opening Bell | Market Mixed At Open; Biotech Stocks Firm; Akeso Jumps 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194971040","media":"HK Opening Bell","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194971040?lang=en_us&edition=fundamental","pubTime":"2026-09-29 09:23","pubTimestamp":1790645038,"startTime":"0","endTime":"0","summary":"1. Market OverviewThe Hang Seng Index inched up 0.02% to 24,648.64 at the open, while the Hang Seng China Enterprises Index gained 0.13% to 8,227.19. The broader market adopted a cautious tone,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"2a636898467c45d29bd1e8ffe7ecce1f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4585","BK4581","XLK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671686982","title":"Healthcare Stocks Rise to Start Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2671686982","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671686982?lang=en_us&edition=fundamental","pubTime":"2026-09-29 05:19","pubTimestamp":1790630340,"startTime":"0","endTime":"0","summary":"Shares of health care companies were among the few winning sectors Monday as the broader market posted losses.Roche Holding said it stopped work on one of its obesity-drug candidates, after clinical-trial data suggested the medicine wouldn't hit internal targets. The Swiss drugmaker said it returned rights to the medicine, emugrobart, to its majority-owned business Chugai Pharmaceutical  which originally discovered the drug and licensed it to Roche. \"We have made the decision to discontinue development,\" Roche's pharmaceuticals chief executive, Teresa Graham, said at an event with investors in London on Monday. \"We are returning that molecule to Chugai, and Chugai is looking to further development in [spinal muscular atrophy] as well as considering potential outlicensing opportunities.\"","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","XBI","XLV","HCSG","BK4585","BK4581","LU0128526141.USD","LU0029874061.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":6,"totalSize":334,"code":"91000000","status":"200"}]}}